This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Apr 14;379(9824):1370-1.

doi: 10.1016/S0140-6736(12)60165-2. Epub 2012 Feb 27.

Could FFAR1 assist insulin secretion in type 2 diabetes?

Clifford J Bailey¹

Affiliations

PMID: 22374407
DOI: 10.1016/S0140-6736(12)60165-2

Comment

Could FFAR1 assist insulin secretion in type 2 diabetes?

Clifford J Bailey. Lancet. 2012.

. 2012 Apr 14;379(9824):1370-1.

doi: 10.1016/S0140-6736(12)60165-2. Epub 2012 Feb 27.

Author

Clifford J Bailey¹

Affiliation

¹ Life and Health Sciences, Aston University, Birmingham B4 7ET, UK. c.j.bailey@aston.ac.uk

PMID: 22374407
DOI: 10.1016/S0140-6736(12)60165-2

No abstract available

PubMed Disclaimer

Comment on

TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.
Burant CF, Viswanathan P, Marcinak J, Cao C, Vakilynejad M, Xie B, Leifke E. Burant CF, et al. Lancet. 2012 Apr 14;379(9824):1403-11. doi: 10.1016/S0140-6736(11)61879-5. Epub 2012 Feb 27. Lancet. 2012. PMID: 22374408 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information